MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$229K
Operating loss
-$223K
Total financial
expense
-$6K
General and
administrative expenses
$186K
Research and development
expenses
$37K
Back
Back
Income Statement
source: myfinsight.com
Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. (RAPH)